Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A genome-wide CRISPR screen identifies regulators of MAPK and MTOR pathways that mediate resistance to sorafenib in acute myeloid leukemia
Alisa Damnernsawad, Daniel Bottomly, Stephen E. Kurtz, et al.
Haematologica (2020) Vol. 107, Iss. 1, pp. 77-85
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer
Mostafa Vaghari‐Tabari, Parisa Hassanpour, Fatemeh Sadeghsoltani, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 67
A new phase of the Cancer Moonshot to end cancer as we know it
Dinah S. Singer
Nature Medicine (2022) Vol. 28, Iss. 7, pp. 1345-1347
Open Access | Times Cited: 37
Understanding ER homeostasis and the UPR to enhance treatment efficacy of acute myeloid leukemia
Martyna Śniegocka, Francesca Liccardo, Francesco Fazi, et al.
Drug Resistance Updates (2022) Vol. 64, pp. 100853-100853
Open Access | Times Cited: 26
Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation
Sisi Chen, Rahul S. Vedula, Antonio Cuevas-Navarro, et al.
Cancer Discovery (2022) Vol. 12, Iss. 10, pp. 2434-2453
Open Access | Times Cited: 23
Therapeutic resistance in acute myeloid leukemia cells is mediated by a novel ATM/mTOR pathway regulating oxidative phosphorylation
Hae J. Park, Mark A. Gregory, Vadym Zaberezhnyy, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 19
The GSK3β/Mcl-1 axis is regulated by both FLT3-ITD and Axl and determines the apoptosis induction abilities of FLT3-ITD inhibitors
Yang Qiu, Ying Li, Meng Chai, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Clinicopathologic Characteristics and Prognostic Profile of Chronic Myeloid Neoplasms With Somatic NF1 Mutations in Adult Patients
Hamza Tariq, Margarita Loxas, Mir Alikhan, et al.
European Journal Of Haematology (2025)
Open Access
Unveiling Pharmacogenomics Insights into Circular RNAs: Toward Precision Medicine in Cancer Therapy
Saud Alqahtani, Taha Alqahtani, Krishnaraju Venkatesan, et al.
Biomolecules (2025) Vol. 15, Iss. 4, pp. 535-535
Open Access
Cathepsin X is a conserved cell death protein involved in algal response to environmental stress
Avia Mizrachi, Mai Sadeh, Shifra Ben‐Dor, et al.
Current Biology (2025)
Open Access
A Receptor Tyrosine Kinase Inhibitor Sensitivity Prediction Model Identifies AXL Dependency in Leukemia
Ahmad Nasimian, Lina Al Ashiri, Mehreen Ahmed, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3830-3830
Open Access | Times Cited: 10
CRISPR screening in hematology research: from bulk to single-cell level
Sarah Meyers, Sofie Demeyer, Jan Cools
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 10
MicroRNA-138-1-3p sensitizes sorafenib to hepatocellular carcinoma by targeting PAK5 mediated β-catenin/ABCB1 signaling pathway
Tongtong Li, Jie Mou, Yao‐Jie Pan, et al.
Journal of Biomedical Science (2021) Vol. 28, Iss. 1
Open Access | Times Cited: 23
CRISPR technology: A versatile tool to model, screen, and reverse drug resistance in cancer
Shiva Shirani-Bidabadi, Aliye Tabatabaee, Nazita Tavazohi, et al.
European Journal of Cell Biology (2023) Vol. 102, Iss. 2, pp. 151299-151299
Open Access | Times Cited: 9
A Bayesian model for unsupervised detection of RNA splicing based subtypes in cancers
David Wang, Mathieu Quesnel-Vallières, San Jewell, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 6
High-Throughput CRISPR Screening in Hematological Neoplasms
Raquel Ancos-Pintado, Irene Bragado-García, María Luz Morales, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3612-3612
Open Access | Times Cited: 8
Increased dosage of wild-type KRAS protein drivesKRAS-mutant lung tumorigenesis and drug resistance
Tonči Ivanišević, Wout Magits, Yan Ma, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
CRISPR screens in mechanism and target discovery for AML
Lin Tian, Dan Liu, Zhangchun Guan, et al.
Heliyon (2024) Vol. 10, Iss. 8, pp. e29382-e29382
Open Access | Times Cited: 1
Functional genomic approaches in acute myeloid leukemia: Insights into disease models and the therapeutic potential of reprogramming
Shyam A. Patel
Cancer Letters (2022) Vol. 533, pp. 215579-215579
Open Access | Times Cited: 5
Recent Advances and Therapeutic Strategies Using CRISPR Genome Editing Technique for the Treatment of Cancer
Shreyasi Maity, Rishyani Mukherjee, Satarupa Banerjee
Molecular Biotechnology (2022) Vol. 65, Iss. 2, pp. 206-226
Closed Access | Times Cited: 5
Targeting C/EBPα overcomes primary resistance and improves the efficacy of FLT3 inhibitors in acute myeloid leukaemia
Hanlin Wang, Guanghao Luo, Xiaobei Hu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 2
A Comprehensive Pan-Cancer Analysis of the Tumorigenic Effect of Leucine-Zipper-Like Transcription Regulator (LZTR1) in Human Cancer
Bo Zhou, Xinyu Ying, Yingcong Chen, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 3
Cathepsin X is a conserved cell death protein involved in algal response to environmental stress
Avia Mizrachi, Mai Sadeh, Shifra Ben‐Dor, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Venetoclax Overcomes Sorafenib Resistance in Acute Myeloid Leukemia by Targeting BCL2
Xi Xu, Weiwei Ma, Guo Qiu, et al.
Biology (2023) Vol. 12, Iss. 10, pp. 1337-1337
Open Access | Times Cited: 1
The high-performance technology CRISPR/Cas9 improves knowledge and management of acute myeloid leukemia
Romeo-Gabriel Mihăilă, Diana Topircean
Biomedical Papers (2021) Vol. 165, Iss. 3, pp. 249-257
Open Access | Times Cited: 3
Novel Therapeutic Approaches for KRAS-Mutated Lung Cancer Involving LZTR1 Genetic Alteration
Raj Nayan Sewduth, Tonči Ivanišević, Peihua Zhao, et al.
(2023), pp. 6-6
Open Access
Page 1 - Next Page

Scroll to top